Previous studies have indicated that vaspin acts as an insulin sensitizer with anti-inflammatory effects and might serve as a compensatory mechanism in the pathogenesis of visceral obesity, type 2 diabetes mellitus (T2DM), and atherosclerosis [6,10,11,12,13,14]. This evidence concerns the gene INS and type 2 diabetes mellitus.